Secukinumab, IL-17 Inhibitor, Approved for Pediatric Psoriasis Secukinumab, IL-17 Inhibitor, Approved for Pediatric Psoriasis

' This has changed the playing field for these children and their families completely, ' said one pediatric dermatologist at the University of California San Francisco.FDA Approvals
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Dermatology News Alert Source Type: news